Located in Malvern, PA, this 104,400 SF building was acquired by Warren Avenue Investors in 2017.
This fully leased building provides investment-grade credit and international tenants with high-quality lab, manufacturing, and flexible office space to serve their needs. With proximity to major life sciences players such as Johnson & Johnson, Merck, Teva, and more — as well as its easy access to major highways – Malvern Research Center at Phoenixville Pike building is well positioned for long-term growth.